IRMA-International.org: Creator of Knowledge
Information Resources Management Association
Advancing the Concepts & Practices of Information Resources Management in Modern Organizations

Gene Editing and Gene Therapies in Cancer Treatment

Gene Editing and Gene Therapies in Cancer Treatment
View Sample PDF
Author(s): Gyanendra Tripathi (Department of Bioengineering, Integral University, India), Maryam Faiyaz (Department of Bioengineering, Integral University, India), Ziaul Hasan (Department of Biosciences, Jamia Millia Islamia, New Delhi, India), Afreen Khanam (Department of Biosciences, Integral University, India)and Arbab Husain (Department of Biosciences, Integral University, India)
Copyright: 2024
Pages: 21
Source title: Research Anthology on Bioinformatics, Genomics, and Computational Biology
Source Author(s)/Editor(s): Information Resources Management Association (USA)
DOI: 10.4018/979-8-3693-3026-5.ch032

Purchase

View Gene Editing and Gene Therapies in Cancer Treatment on the publisher's website for pricing and purchasing information.

Abstract

In past years, several novel treatments have been given by gene therapies for the treatment of cancer. Gene-based therapeutic approaches include gene transfer, oncolytic virotherapy, and immunotherapy. Gene Transfer or gene editing is the most recent treatment method that allows the insertion of new genes into the cancer cell to mediate the slow growth or death of the cancerous cell. Gene transfer is a very flexible technique, and a wide range of genes and vectors are being used in clinical trials with positive results. CRISPR/Cas9 is found to be a promising technology in cancer research. It helps to dissect the mechanism of tumorigenesis, identify the target for drug development, and helps in the cell-based therapies. Oncology virotherapy uses viral particles that are capable of replicating within the cancer cell and results in cell death. Oncology virotherapy has shown great efficiency in metastatic cancer. In immunotherapy, cells and viral particles are genetically modified before being introduced within the patient's body to trigger the host immune response to destroy cancer cells.

Related Content

Alessandra Lima da Silva, Diego Mariano, Mariana Parise, Angie L. A. Puelles, Tatiane Senna Bialves, Luana Luiza Bastos, Lucas Santos, Rafael Pereira Lemos. © 2025. 22 pages.
Seyyed Mohammad Amin Mousavi Sagharchi, Mohsen Sheykhhasan, Atousa Ghorbani, Elina Afrazeh, Naresh Poondla, Naser Kalhor, Hamid Tanzadehpanah, Hanie Mahaki, Hamed Manoochehri. © 2025. 46 pages.
Eduarda Guimarães Sousa, Lucas Gabriel Rodrigues Gomes, Fernanda Diniz Prates, Talita Pereira Gomes, Gabriel Camargos Gomes, Janaíne Aparecida de Paula, Ana Lua de Oliveira Vinhal, Bernardo Buhr Alves Mendonça, Mariana Letícia Costa Pedrosa, Luiza Pereira Reis, Aline Ferreira Maciel de Oliveira, Marcus Vinicius Canário Viana, Arun Kumar Jaiswal, Siomar de Castro Soares, Vasco Ariston de Carvalho Azevedo. © 2025. 38 pages.
Diego Mariano, Lucas Moraes dos Santos, Raquel Cardoso de Melo-Minardi. © 2025. 30 pages.
Alessandra G. Cioletti, Frederico C. Carvalho, Lucas M. Dos Santos, Raquel C. M. Minardi. © 2025. 32 pages.
Leandro Morais de Oliveira, Luana Luiza Bastos, Vivian Morais Paixão, Leticia Aparecida Gontijo, Tatiane Senna Bialves, Diego Mariano, Raquel Cardoso de Melo Minardi. © 2025. 40 pages.
Angie Atoche Puelles, Luana Luiza Bastos, Vivian Morais Paixão, Sheila Cruz Araujo, Raquel Cardoso de Melo Minardi. © 2025. 28 pages.
Body Bottom